Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Narrative)

v3.10.0.1
Commitments and Contingencies (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jan. 30, 2018
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
[1]
Other current liabilities   $ 58   $ 58   $ 250
Contingent obligation   1,906   1,906   1,662
General and administrative expense   2,145 $ 2,414 6,021 $ 4,907  
Other long-term liabilities   84   84  
Financing expense   85 $ 72 244 $ 207  
License and Supply Agreement (Coated Products) [Member]            
Description of royalty payment <p style="font: 10pt Times New Roman, Times, Serif">a. 2% of the first $25 million in annual net sales of Coated Products; and</p> <p style="font: 10pt Times New Roman, Times, Serif">b. 1.5% once annual net sales exceed $25 million of Coated Products.</p>          
Description of minimum royalty payment <p style="font: 10pt Times New Roman, Times, Serif">a. January 1, 2020 to December 31, 2020 - $5 per calendar quarter;</p> <p style="font: 10pt Times New Roman, Times, Serif">b. January 1, 2021 to December 31, 2021 - $10 per calendar quarter;</p> <p style="font: 10pt Times New Roman, Times, Serif">c. January 1, 2022 and beyond - $15 per calendar quarter.</p>          
Description of royalty payment for one-time milestone <p style="font: 10pt Times New Roman, Times, Serif">a. $12.5 due 6 months after the first commercial sale of a Coated Product.</p> <p style="font: 10pt Times New Roman, Times, Serif">b. $12.5 due 12 months after the first commercial sale of a Coated Product.</p> <p style="font: 10pt Times New Roman, Times, Serif">c. $25 due 18 months after the first commercial sale of a Coated Product.</p>          
Other current liabilities   13   13    
General and administrative expense   0   50    
Other long-term liabilities   37   $ 37    
Royalty Arrangements To Israel Innovation Authority [Member]            
Description of royalty payment       <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="font: 10pt Calibri, Helvetica, Sans-Serif; width: 100%">Royalties ranging from 3% to 3.5% of revenues on sales of products and services based on technology developed using IIA grants, up to an aggregate of 100% (which may be increased under certain circumstances) of the U.S. dollar-linked value of the grant, plus interest at the rate of 12-month LIBOR.</td></tr> </table>    
Royalty received       $ 1,332    
Contingent obligation   $ 1,382   $ 1,382    
[1] Derived from audited consolidated financial statements